Verrica pharmaceuticals investigation continued by former louisiana attorney general: kahn swick & foti, llc continues to investigate the officers and directors of verrica pharmaceuticals inc. - vrca

New orleans--(business wire)--former attorney general of louisiana, charles c. foti, jr., esq., a partner at the law firm of kahn swick & foti, llc (“ksf”), announces that ksf continues its investigation into verrica pharmaceuticals inc. (nasdaqgm: vrca). in december 2020, the company submitted a new drug application (“nda”) to the u.s. food and drug administration (“fda”) for regulatory approval of its lead product, vp-102 or ycanth, for the treatment of molluscum contagiosum, a skin disea.
GM Ratings Summary
GM Quant Ranking